8-K filing — Aspire Biopharma Holdings, Inc. (ASBPW)
Filed: 2026-08-19 AccNo: 0001493152-26-039135 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
8-K filing — Aspire Biopharma Holdings, Inc. (ASBPW)
Filed: 2026-07-20 AccNo: 0001493152-26-033942 Size: 252 KB Item 8.01: Other Events
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 20, 2026, 9:20 PM
- Checked
- Jul 20, 2026, 9:20 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th
Aspire Biopharma Holdings (ASBP) announced it will present live at the Life Sciences Investor Forum on June 25th, 2026. The company highlighted its multiple prescription applications in cardiovascular and other therapeutic areas, its lead drug candidate high-dose aspirin product, and the commercial launch of BUZZ BOMB caffeine product. Aspire also announced a proposed acquisition of Dura Driver Control Systems, expected to close in Q3 2026.
Read original at globenewswire-inc